MIRACLETOX TIME REWIND PERFECTION VIP PROGRAM
niacinamide, adenosine kit |
Product Information |
Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC: 71619-001 |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 71619-001-01 | 1 in 1 BOX; Type 0: Not a Combination Product | 02/20/2020 | |
|
Quantity of Parts |
Part # | Package Quantity | Total Product Quantity |
Part 1 | 1 POUCH | 30 g |
Part 2 | 1 CONTAINER | 2 g |
Part 3 | 1 BOTTLE | 50 g |
Part 4 | 1 CONTAINER | 40 mL |
|
Part 1 of 4 |
MIRACLETOX TIME REWIND PERFECTION MASK
niacinamide, adenosine patch |
|
Product Information |
Item Code (Source) | NDC: 71619-200 |
Route of Administration | TOPICAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.6 g in 30 g |
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.01 g in 30 g |
|
Inactive Ingredients |
Ingredient Name | Strength |
WATER (UNII: 059QF0KO0R) | |
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 71619-200-02 | 4 in 1 CARTON | | |
1 | NDC: 71619-200-01 | 30 g in 1 POUCH; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 02/20/2020 | |
|
Part 2 of 4 |
MIRACLETOX TIME REWIND PERFECTION TOX AMPOULE
niacinamide, adenosine liquid |
|
Product Information |
Item Code (Source) | NDC: 71619-210 |
Route of Administration | TOPICAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.04 g in 2 g |
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.0008 g in 2 g |
|
Inactive Ingredients |
Ingredient Name | Strength |
WATER (UNII: 059QF0KO0R) | |
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 71619-210-02 | 4 in 1 CARTON | | |
1 | NDC: 71619-210-01 | 2 g in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 07/26/2019 | |
|
Part 3 of 4 |
MIRACLETOX TIME REWIND PERFECTION FEEL
niacinamide, adenosine cream |
|
Product Information |
Item Code (Source) | NDC: 71619-190 |
Route of Administration | TOPICAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 1 g in 50 g |
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.02 g in 50 g |
|
Inactive Ingredients |
Ingredient Name | Strength |
WATER (UNII: 059QF0KO0R) | |
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | | 50 g in 1 BOTTLE; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 02/20/2020 | |
|
Part 4 of 4 |
MIRACLETOX TIME REWIND ADVANCED LIFTING AMPOULE
40ML
niacinamide, adenosine liquid |
|
Product Information |
Item Code (Source) | NDC: 71619-180 |
Route of Administration | TOPICAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) | ADENOSINE | 0.016 g in 40 mL |
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) | NIACINAMIDE | 0.8 g in 40 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 71619-180-02 | 1 in 1 CARTON | | |
1 | NDC: 71619-180-01 | 40 mL in 1 CONTAINER; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 02/20/2020 | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 02/20/2020 | |
|